GSK - GlaxoSmithKline PLC ADR - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GSK is currently covered by 6 analysts with an average price target of $31.94. This is a potential upside of $-5.88 (-15.55%) from yesterday's end of day stock price of $37.82.

GlaxoSmithKline PLC ADR's activity chart (see below) currently has 127 price targets and 86 ratings on display. The stock rating distribution of GSK is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.49% with an average time for these price targets to be met of 314.28 days.

Highest price target for GSK is $41, Lowest price target is $41, average price target is $43.33.

Most recent stock forecast was given by KERRY HOLFORD from BERENBERG on 01-Dec-2024. First documented stock forecast 27-Jul-2014.

Currently out of the existing stock ratings of GSK, 3 are a HOLD (33.33%), 6 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$41

$2.72 (7.11%)

7 months 14 days ago
(01-Dec-2024)

1/1 (100%)

$6.69 (19.50%)

179

Hold

$53

8 months 4 days ago
(11-Nov-2024)

2/4 (50%)

$15.58 (41.64%)

379

Buy

11 months 15 days ago
(31-Jul-2024)

1/13 (7.69%)

$-10.5 (-32.65%)

64

Buy

$45

$6.72 (17.55%)

$47

1 years ago
(15-Jul-2024)

1/3 (33.33%)

$6.9 (18.11%)

2259

Buy

$19.52

1 years 5 months 3 days ago
(12-Feb-2024)

0/3 (0%)

$-13.88 (-41.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GSK (GlaxoSmithKline PLC ADR) average time for price targets to be met?

On average it took 314.28 days on average for the stock forecasts to be realized with a an average price target met ratio 25.49

Which analyst has the current highest performing score on GSK (GlaxoSmithKline PLC ADR) with a proven track record?

JUSTIN SMITH

Which analyst has the most public recommendations on GSK (GlaxoSmithKline PLC ADR)?

Justin Smith works at SOCGEN and has 3 price targets and 2 ratings on GSK

Which analyst is the currently most bullish on GSK (GlaxoSmithKline PLC ADR)?

John Eade with highest potential upside - $6.72

Which analyst is the currently most reserved on GSK (GlaxoSmithKline PLC ADR)?

Eric Le Berrigaud with lowest potential downside - -$22.45

GlaxoSmithKline PLC ADR in the News

UK MHRA issues alert on 'small risk' of Guillain-Barré syndrome with RSV vaccines

[Human respiratory syncytial virus inoculation] Hailshadow * The UK’s Medicines & Healthcare products Regulatory Agency has issued a drug safety update regarding a “small risk” of Guillain-Barré syndrome associated with individuals who have received respiratory syncytial virus (RSV) vaccines made by GSK (NYSE:GSK [https://seekingalpha.com/symbol/GSK]) and Pfizer (NYSE:PFE [https://seekingalpha.com/symbol/PFE]). * The former markets Arexvy; the latter,...

GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis

Premiering on Lifetime on June 28, 2025, at 8 p.m. ET/7 p.m. CT, Pretty Hurts, brought to you by GSK, features a storyline that aims to raise awareness among parents about meningococcal disease, known as meningitis, an uncommon but serious illness that teens and young adults aged 16-23 are at an increased risk for.Alyson Hannigan,...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?